Dark

Check out our Level2View

REC
Emles Real Estate Credit ETF
stock BATS

Inactive

May 23, 2025

34.35USD-0.550%(-0.19)200

Pre-market

0.00USD-100.000%(-34.54)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Mar 23, 2021

04:00AM EDT RECORDATI POSITIVE RESULTS FROM THE PHASE III LINC 4 STUDY PRESENTED AT THE ENDOCRINE SOCIETYS ANNUAL MEETING REINFORCE THE EFFICACY AND SAFETY OF ISTURISA (OSILODROSTAT) IN CUSHINGS DISEASE GlobeNewswire Inc

Feb 22, 2021

07:20AM EST RECORDATI: PRELIMINARY 2020 RESULTS CONFIRM CONTINUED GROWTH OF OPERATING INCOME AND NET INCOME. EBITDA +4.7% AND ADJUSTED NET INCOME +7.3%. GlobeNewswire Inc

Jan 29, 2021

12:11PM EST RECORDATI: LICENSE OBTAINED FOR THE COMMERCIALIZATION OF ELIGARD IN EUROPE AND OTHER COUNTRIES GlobeNewswire Inc

Nov 30, 2020

08:01AM EST RECORDATI: MARKET AUTHORIZATION APPLICATION FOR ARS-1 (EPINEPHRINE NASAL SPRAY) ACCEPTED BY EUROPEAN MEDICINES AGENCY GlobeNewswire Inc

Oct 29, 2020

08:16AM EDT RECORDATI: PROFIT GROWTH IN THE FIRST NINE MONTHS OF 2020. REVENUES -0.6%, EBITDA +7.1%, ADJUSTED NET INCOME +12.3% GlobeNewswire Inc

Oct 1, 2020

12:13PM EDT RECORDATI: MERGER BY ABSORPTION OF FIMEI S.P.A. AND ROSSINI INVESTIMENTI S.P.A. INTO RECORDATI S.P.A. APPROVED GlobeNewswire Inc

Sep 22, 2020

08:01AM EDT ARS Pharmaceuticals and Recordati Announce Exclusive License for the Rights in PR Newswire

Sep 21, 2020

02:27PM EDT RECORDATI LICENSES AN INNOVATIVE EPINEPHRINE NASAL SPRAY IN DEVELOPMENT FOR ANAPHYLAXIS PREVENTION GlobeNewswire Inc

Jul 30, 2020

08:10AM EDT RECORDATI ANNOUNCES POSITIVE FIRST HALF 2020 RESULTS. REVENUES +2.3%, EBITDA +11.4%, ADJUSTED NET INCOME +16.8% GlobeNewswire Inc

Share